Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Carvedilol Exerts Cardioprotective Effects Against Doxorubicin Toxicity via Autophagy Modulation and Energetics Restoration.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

Impact of preanalytical factors on liquid biopsy in the canine cancer model.

Communications medicine·2026

Same author

Integrated Multiomic Profiling Enhances Risk Stratification and Prognostication in Canine Osteosarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL.

Scientific reports·2026

Same author

Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic Lesions.

bioRxiv : the preprint server for biology·2026

Same author

Peripheral Blood Mononuclear Cell Gene Expression Signatures Predict Long-term Survivorship in Canine DLBCL.

Research square·2025

Same journal

Introduction.

Annual review of animal biosciences·2026

Same journal

Topological Approaches in Animal Comparative Genomics.

Annual review of animal biosciences·2026

Same journal

Immunogenomics Approaches to Studying Antibody Repertoires and Vaccine Responses in Ruminants.

Annual review of animal biosciences·2025

Same journal

New Frontiers in Animal Prion Diseases.

Annual review of animal biosciences·2025

Same journal

Evolution of Mammalian Regulatory Networks in the Brain.

Annual review of animal biosciences·2025

Same journal

From Discovery to Preservation: The Changing Face of Tasmanian Devil Research.

Annual review of animal biosciences·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 21, 2026

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Dogs as a Model for Cancer: An Update.

Joelle M Fenger¹, Cheryl A London²

¹Ethos Discovery, Westborough, Massachusetts, USA.

Annual Review of Animal Biosciences

|February 19, 2026

Summary

This summary is machine-generated.

Client-owned dogs with cancer serve as valuable preclinical models, mirroring human disease and aiding cancer drug development. This approach optimizes therapies for humans and provides pets with advanced treatment options.

Keywords:

cancer clinical trials comparative oncology dog preclinical model

More Related Videos

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

Related Experiment Videos

Last Updated: Feb 21, 2026

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

Area of Science:

Comparative oncology
Translational cancer research
Veterinary medicine

Background:

Spontaneous canine cancers closely mimic human cancers in clinical and molecular aspects.
Dogs with cancer offer a naturally occurring model for studying cancer progression and treatment resistance.

Purpose of the Study:

To highlight the utility of pet dogs with cancer in preclinical drug development.
To improve the efficiency and success rate of cancer therapeutic development for both humans and animals.

Main Methods:

Leveraging spontaneous canine cancer models in preclinical drug development.
Analyzing molecular drivers and immune landscapes in canine cancers.
Establishing pharmacokinetic/pharmacodynamic relationships and clinical toxicities in dogs.

Main Results:

Canine cancer models have informed dose regimens and identified potential biologic activity of therapeutics.
This approach helps eliminate therapies with low potential early in development.
Optimized therapies show greater probability of success in human clinical trials.

Conclusions:

Integrating pet dogs into cancer drug development accelerates the identification of effective treatments.
This translational model benefits both human and veterinary oncology.
Further research into canine cancer can lead to significant advancements in cancer therapy.